Erasca, Inc.

Contributing Author

Recent Articles by Erasca, Inc.

3 hours	Erasca Announces Pricing of Upsized Public Offering of Common Stock ERAS GlobeNewswire
Jan-20	Erasca Announces Proposed Public Offering of $150 Million of Common Stock ERAS GlobeNewswire
Jan-12	Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones ERAS GlobeNewswire
Jan-06	Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference ERAS GlobeNewswire
Nov-25	Erasca to Present at the 8th Annual Evercore Healthcare Conference ERAS GlobeNewswire
Nov-12	Erasca Reports Third Quarter 2025 Business Updates and Financial Results ERAS GlobeNewswire
Nov-06	Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015 ERAS GlobeNewswire
Nov-04	Erasca to Present at Upcoming Conferences in November ERAS GlobeNewswire
Sep-02	Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference ERAS GlobeNewswire
Aug-12	Erasca Reports Second Quarter 2025 Business Updates and Financial Results ERAS GlobeNewswire
Jun-02	Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001 ERAS GlobeNewswire
May-29	Erasca to Present at Upcoming Investor Conferences in June ERAS GlobeNewswire
May-13	Erasca Reports First Quarter 2025 Business Updates and Financial Results ERAS GlobeNewswire
May-13	Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway ERAS GlobeNewswire
May-07	Erasca to Present at the Bank of America Securities Health Care Conference ERAS GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.